Edwards Lifesciences
408 hedge funds and large institutions have $6.53B invested in Edwards Lifesciences in 2013 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 112 increasing their positions, 173 reducing their positions, and 67 closing their positions.
38.77% more ownership
Funds ownership: 505.99% → 544.76% (+39%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 67
0% less funds holding
Funds holding: 409 → 408 (-1)
1% less capital invested
Capital invested by funds: $6.59B → $6.53B (-$59.2M)
8% less call options, than puts
Call options by funds: $81.4M | Put options by funds: $88.8M
35% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 173
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$270M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$186M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$126M |
| 4 |
JP
Jana Partners
New York
|
+$105M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$52.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$101M |
| 2 |
BAMCO Inc
New York
|
-$43.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$42.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$42.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$41.1M |
EW Hedge Fund Activity: Q4 2013 in Review
408 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q4 2013, worth a combined $6.53B — down 0.9% from $6.59B a quarter earlier.
Fund positioning in EW was balanced in Q4 2013: 67 funds opened new positions, 67 closed out, 112 added to existing stakes and 173 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $270M. The largest seller was Goldman Sachs, cutting an estimated $101M.
- 408 institutional investors held Edwards Lifesciences (EW) as of Q4 2013, down from 409 in Q3 2013.
- Funds reported $6.53B of Edwards Lifesciences stock for Q4 2013, down 0.9% quarter-over-quarter.
- 67 funds opened new Edwards Lifesciences positions in Q4 2013 and 67 closed out, a net change of 0 holders.
- The largest Edwards Lifesciences buyer in Q4 2013 was Wellington Management Group, an estimated $270M added.
- The largest Edwards Lifesciences seller in Q4 2013 was Goldman Sachs, an estimated $101M sold.
Based on aggregated 13F filings for Q4 2013.